Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method and application of PAAs@MnO(OH)-RGD drug release carrier

A carrier and drug technology, applied in the field of PAAsMnO-RGD drug release carrier, can solve the problems of small contrast agent r1 value, high price change, difficult to form complexes, etc., and achieve the effects of easy degradation, simple preparation process, and reduced usage

Inactive Publication Date: 2016-07-27
FUZHOU UNIV
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Mn is not easy to form complexes, and the price changes more, so the r1 value of the contrast agent developed based on manganese oxide is small (generally 0.5mM -1 ·S -1 )

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of PAAs@MnO(OH)-RGD drug release carrier
  • Preparation method and application of PAAs@MnO(OH)-RGD drug release carrier
  • Preparation method and application of PAAs@MnO(OH)-RGD drug release carrier

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The aqueous solution of PAAsMnO(OH) composite nanospheres was ultrasonically treated for 0.5h, then dropped on the copper grid, dried and then scanned by TEM (see Figure 1(A), Figure 1(B)). The results are shown in Figure 1(A), As shown in Figure 1(B), it can be seen from Figure 1(A) that the PAAsMnO(OH) composite nanomaterial is a nanosphere structure with uniform size and an average diameter of about 80nm; The diameter of the MnO(OH) nanoparticles on the surface is about 2nm, uniform in size and uniform in distribution (pointed by the arrow). From the XRD test results, it can be seen that what is wrapped on the product PAAs is manganese oxyhydroxide nanoparticles (see figure 2).

Embodiment 2

[0035] Add the PAAsMnO(OH) complex and doxorubicin (DOX) to the PBS (10mM, pH=7.4) solution at a mass concentration of 1:1, shake at room temperature for 12 hours in the dark, centrifuge, and wash with PBS (10mM, pH=7.4) Wash the solution, collect the supernatant, calculate the amount of DOX contained therein according to the standard curve of DOX, and further calculate the load of DOX as 0.911mgDOX / 1mgPAAsMnO(OH). Disperse 1mg of the PAAsMnO(OH) complex after adsorbing the drug in 3ml of PBS (10mM, pH=7.4) solution, put it into the dialysis bag, add the dialysis bag to 47ml of PBS solution for dialysis for 48h, every 1h, 2h, 4h, 6h, 8h, 10h, 12h, 14h, 16h, 24h, 36h, 48h, take 3ml solution to measure fluorescence, then add 3ml PBS solution to the original solution, the test results are as follows image 3 Shown: Curve 1 is normal temperature, pH=7.4; Curve 2 is normal temperature, pH=7.4, 2mMDTT; Curve 3 is normal temperature, pH=5; Curve 4 is normal temperature, pH=5, 2mMDTT;...

Embodiment 3

[0037] HepG2 cells were used as target cancer cells to examine the cell biocompatibility of PAAsMnO(OH) nanomaterials: the liver cancer HepG2 cells were seeded in a 96-well plate, the culture medium required by the cells was added, and then cultured in a cell incubator for 24 hours, Take out the culture solution, add the PAAsMnO(OH) nanomaterial prepared in Example 1, and its concentration is divided into PAAsMnO(OH) complexes of 5 μg / ml, 15 μg / ml, 25 μg / ml, 50 μg / ml and 100 μg / ml to carry out In the MTT test, four groups were paralleled for each concentration. After culturing for 24 hours, the absorbance value was read at 490 nm on a microplate reader, and the survival rate of cells in each group was calculated according to the absorbance values ​​of the blank group and the sample group. From Figure 4 It can be seen from the results that the survival rate of cells in each group is above 90%, indicating that the PAAsMnO(OH) nanospheres have good biocompatibility and no obviou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Diameteraaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a preparation method and application of a PAAs@MnO(OH)-RGD drug release carrier.The preparation method comprises the steps of firstly, assembling a manganese oxide hydroxide shell layer on the surface of a sodium polyacrylate nanosphere, so that a composite nanosphere is obtained; making the composite nanosphere be subjected to electrostatic adsorption action, and adsorbing RGD polypeptide molecules to the surface of the composite nanosphere, so that the drug release carrier is obtained.The drug release carrier prepared through the method has the characteristics of tumor location pH and reducing agent dual-response magnetic resonance imaging and drug controlled release and meanwhile has the advantages of being high in drug load rate, biodegradable and the like, and therapy integrating nuclear magnetic imaging, drug delivery and release and targeting on tumors or inflammatory tissues can be achieved.

Description

technical field [0001] The invention belongs to the field of nanomaterial preparation, and in particular relates to a PAAsMnO(OH)-RGD drug release carrier and its application. Background technique [0002] Tumor is a common and frequently-occurring disease, among which malignant tumor is the most serious disease that endangers human health. According to the latest disease data in my country, in the latest "2015 China Tumor Registration Annual Report", every minute, 6 people across the country are diagnosed with malignant tumors, and 5 people die of cancer. Therefore, with the increasing morbidity and mortality of tumors, we urgently need new and more effective diagnostic and therapeutic methods. In recent years, with the emergence of nanomaterials, multifunctional nanomaterials provide a new solution for the integration of tumor diagnosis and treatment. This multifunctional nanocarrier is a single nanomaterial with gaps that is simultaneously modified with a variety of bio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K49/12A61K49/14A61K49/18A61K9/16A61K31/704A61K47/18A61K47/32A61P35/00
CPCA61K9/1676A61K31/704A61K47/183A61K47/32A61K49/126A61K49/14A61K49/1878
Inventor 朱春玲蒋有华柯淑娟曾胚羡谢增鸿
Owner FUZHOU UNIV